Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Haleon PLC

HLN ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Pharmaceuticals ·

USA Large Cap Analyst: BUY

Last Close

$9.70

▼ -1.02%

Market Cap $42.24B · Vol 682.20K

Key Metrics

P/E Ratio

19.85

FWD: 20.65

Market Cap

$42.24B

Large Cap

Div Yield

2.05%

Semi-annual dividend

EPS Growth

-12.34%

YoY

RSI (14)

41.55

Momentum

Beta

0.09

vs Market

52W High

$11.28

13.97% below

52W Low

$8.66

12.07% above

Volume

682.20K

Avg 2.29M

P/B

2.03

Price-to-book

ROE

10.41%

Return on equity

Free Float

99.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Haleon PLC (HLN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HLN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.29%

+0.00%

+8.87%

-13.39%

YTD

-4.06%

+0.00%

+13.32%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$14.86B
Net Income	$2.26B
Revenue Growth (YoY)	+2.23%
Gross Margin	65.01%
Operating Margin	22.78%
Net Profit Margin	15.23%
ROE	10.41%
ROA · ROIC	6.43% · 7.53%

P/E Ratio	19.85
Forward P/E (FY1)	20.65
PEG Ratio	1.16
P/S	3.07
P/B	2.03
P/FCF	17.60
EPS Growth	-12.34%
Outstanding Shares	8.81B

Technical Indicators

50-Day SMA	$9.59
200-Day SMA	$9.81
RSI (14)	41.55
Beta	0.09
52-Week High	$11.28
52-Week Low	$8.66

Volume Today	682.20K
Avg Daily Volume (30D)	2.29M
Relative Volume	0.30x
Volatility (10D)	13.83
Volatility (30D)	21.52
Free Float	99.98%

Analyst Consensus

BUY

Current Price $9.70

Mean Target $10.97

52W Low$8.66 52W High$11.28

Current

Target

$8.66 $11.28

Current Analyst target

+13.14% upside potential · 5 analysts

Identifiers

ExchangeNYSE

FIGIBBG018GZNDB0

ISINUS4055521003

CountryUnited Kingdom

Sub-IndustryPharmaceuticals (NEC)

Earnings DateAug 3, 2026

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.